464490 — QuadMedicine Balance Sheet
0.000.00%
Last trade - 00:00- KR₩202bn
- KR₩206bn
- KR₩9bn
Annual balance sheet for QuadMedicine, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2023 December 31st | 2024 December 31st | |
|---|---|---|
| Period Length: | — | — |
| Source: | PROSPECTUS | PROSPECTUS |
| Standards: | IFRS | IFRS |
| Status: | Final | Final |
| Cash and Equivalents | ||
| Cash and Short Term Investments | 4,449 | 10,263 |
| Net Total Accounts Receivable | ||
| Net Total Receivables | 37.7 | 1,104 |
| Prepaid Expenses | ||
| Total Other Current Assets | ||
| Total Current Assets | 5,049 | 11,686 |
| Gross Property, Plant And Equipment | ||
| Accumulated Depreciation | ||
| Net Property, Plant And Equipment | 19,549 | 19,752 |
| Net Intangible Assets | ||
| Long Term Investments | ||
| Other Long Term Assets | ||
| Total Assets | 25,219 | 32,098 |
| Notes Payable / Short Term Debt | ||
| Current Portion of Long Term Debt / Capital Leases | ||
| Total Other Current Liabilities | ||
| Total Current Liabilities | 3,912 | 6,330 |
| Long Term Debt | ||
| Capital Lease Obligations | ||
| Total Long Term Debt | ||
| Total Debt | ||
| Total Other Liabilities | ||
| Total Liabilities | 16,256 | 20,498 |
| Common Stock | ||
| Additional Paid In Capital | ||
| Retained Earnings (Accumulated Deficit) | ||
| ESOP Debt Guarantee | ||
| Other Equity | ||
| Total Equity | 8,963 | 11,600 |
| Total Liabilities & Shareholders' Equity | 25,219 | 32,098 |
| Total Common Shares Outstanding |